Showing results (631-640 of 653) with videos related to
Sort By:
Pageof 66
Hepatology International|August 10, 2021
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignanciesTakanori Ito, Masatoshi Ishigami, Takafumi Yamamoto, et al.Annals of Surgical Oncology|November 11, 2023
Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal MetastasisDaisuke Kobayashi, Yasuhiro Kodera, Ryoji Fukushima, et al.Cancer Gene Therapy|November 8, 2021
Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of originDai Shimizu, Kenzui Taniue, Yusuke Matsui, et al.Hepato-Gastroenterology|July 16, 2015
Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced CancerHideki Kasuya, Yasuhiro Kodera, Akimasa Nakao, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 2, 2020
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trialKazumasa Fujitani, Kohei Shitara, Atsuo Takashima, et al.International Journal of Clinical Oncology|January 25, 2020
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncologyYoichi Naito, Saori Mishima, Kiwamu Akagi, et al.Trials|September 17, 2021
ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trialKen-Ichi Okada, Manabu Kawai, Seiko Hirono, et al.Nagoya Journal of Medical Science|March 20, 2024
Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancerKoki Nakanishi, Chie Tanaka, Mitsuro Kanda, et al.Journal of Gastroenterology|October 19, 2022
Clinical practice guidelines for duodenal cancer 2021Kenji Nakagawa, Masayuki Sho, Mitsuhiro Fujishiro, et al.Journal of Hepato-Biliary-Pancreatic Sciences|June 20, 2015
Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matchingMasafumi Nakamura, Go Wakabayashi, Yoshihiro Miyasaka, et al.Pageof 66